Evidence map›Paper›PMID 40264758›Full record

ArticleFrontiers in immunology2025

Manganese deficiency or dietary manganese(III) oxide nanoparticle supplementation: consequences for hematology, and intestinal and brain immunity in rats.

Karolina Różaniecka-Zwolińska, Ewelina Cholewińska, Bartosz Fotschki, Jerzy Juśkiewicz, Katarzyna Ognik

Abstract read
In one paragraph

Article in Frontiers in immunology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. MnAntioxidants (Basel, Switzerland) · 2026
    Article
  4. Manganese Deficiency and MnInternational journal of molecular sciences · 2025
    Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Karolina Różaniecka-ZwolińskaDepartment of Biochemistry and Toxicology, Faculty of Animal Sciences and Bioeconomy, University of Life Sciences in Lublin, Lublin, Poland.
Ewelina CholewińskaDepartment of Biochemistry and Toxicology, Faculty of Animal Sciences and Bioeconomy, University of Life Sciences in Lublin, Lublin, Poland.
Bartosz FotschkiDivision of Food Science, Institute of Animal Reproduction and Food Research, Polish Academy of Sciences, Olsztyn, Poland.
Jerzy JuśkiewiczDivision of Food Science, Institute of Animal Reproduction and Food Research, Polish Academy of Sciences, Olsztyn, Poland.
Katarzyna OgnikDepartment of Biochemistry and Toxicology, Faculty of Animal Sciences and Bioeconomy, University of Life Sciences in Lublin, Lublin, Poland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: The study aimed to determine the effect of manganese (Mn) exclusion from the mineral mixture added to the rat diet and replacing the recommended level of MnCO Methods: The experiment was conducted on twenty-four, Wistar rats divided into 3 equal groups. The control (K) group received a diet containing 65 mg/kg of additional Mn originating from the mineral mixture), group B (negative control) was fed a diet deprived of Mn from the mineral mixture, and group N was fed a diet containing 65 mg/kg Mn from Mn2O3NPs preparation. All rats received the experimental diets for 12 weeks. At the end of the experiment, samples of blood, jejunum, and brain were collected from all rats from each group. Results: Mn exclusion from the rat diet led to anemia, worsened the body's immune response, and caused systemic and local inflammation as indicated e.g. by decreased RBC, HCT, and the level of HGB, and CRP in blood, CRP and IgA in the jejunum, and IgG in the brain as well as an increased level of IL-2, IgG and TNF-α in blood, and IL-6 in jejunum. In turn, replacing the recommended level of MnCO Discussion: The obtained results may suggest that the body has activated adaptive mechanisms that efficiently limit the spread of immune system disorders throughout the body.

Indexed as

BrainDietary SupplementsJejunumManganeseManganese CompoundsNanoparticlesOxidesAnimalsCytokinesMaleRatsRats, WistarCytokinesManganeseManganese Compoundsmanganese oxideOxidesbrainimmune statusinflammationjejunummanganese carbonatemanganese (III) oxide nanoparticles

Identifiers

PMID40264758
PMCPMC12011558

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.